PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer

<p>PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) &#8212; PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell activating platforms, today announced the appointment of Lars Boesgaard as Chief Financial Officer (CFO), [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/pds-biotech-appoints-lars-boesgaard-as-chief-financial-officer/">PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>